Promises and pitfalls of Pseudomonas aeruginosa lipopolysaccharide as a vaccine antigen. (Q35606107)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14670716%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

review article

1 reference

title

Promises and pitfalls of Pseudomonas aeruginosa lipopolysaccharide as a vaccine antigen (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14670716%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

main subject

lipopolysaccharide

0 references

Pseudomonas aeruginosa

object named as

Pseudomonas aeruginosa

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14670716%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Gerald B Pier

series ordinal

1

1 reference

9 August 2017

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14670716%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

published in

Carbohydrate Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14670716%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

338

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14670716%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14670716%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

2549-2556

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14670716%20AND%20SRC:MED&resulttype=core&format=json

Pulmonary infections in patients with cystic fibrosis

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Prevention of invasive pseudomonas infection in burns with a new vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Structural analysis of the lipopolysaccharide core of a rough, cystic fibrosis isolate of Pseudomonas aeruginosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Structural studies on the core and the O-polysaccharide repeating unit of Pseudomonas aeruginosa immunotype 1 lipopolysaccharide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Pseudomonas aeruginosa lipopolysaccharide: evidence that the O side chains and common antigens are on the same molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Analysis of a common-antigen lipopolysaccharide from Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Polysaccharide antigens of Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Serologic types of Pseudomonas aeruginosa based on heat-stable O antigens: correlation of Habs' (European) and Verder and Evans' (North American) classifications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Survey of Heat-Stable, Major Somatic Antigens of Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Somatic antigens of Pseudomonas aeruginosa. The structure of the O-specific polysaccharide chains of lipopolysaccharides of P. aeruginosa serogroup O4 (Lányi) and related serotype O6 (Habs) and immunotype 1 (Fisher)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Somatic antigens of Pseudomonas aeruginosa. The structure of O-specific polysaccharide chains of lipopolysaccharides of P. aeruginosa O3 (Lányi), O25 (Wokatsch) and Fisher immunotypes 3 and 7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Genetic variation at the O-antigen biosynthetic locus in Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Immunization against Pseudomonas in infection after thermal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Immunological Control of Pseudomonas Infection in Burn Patients: A Clinical Evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Use of a Pseudomonas Aeruginosa vaccine in pateints with acute leukemia and cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Preliminary investigations of Pseudomonas aeruginosa vaccine in patients with leukemia and cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

A New Polyvalent Pseudomonas Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Low mortality in burned patients in a Pseudomonas vaccine trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Controlled trials of a polyvalent pseudomonas vaccine in burns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Immunization of noncolonized cystic fibrosis patients against Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Pneumococcal conjugate vaccines: proceedings from an interactive symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Safety, pharmacokinetics, and functional activity of human anti-Pseudomonas aeruginosa monoclonal antibodies in septic and nonseptic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Pharmacokinetics, tolerability, and preliminary efficacy of human anti-Pseudomonas aeruginosa monoclonal antibodies in pneumonia and burn infection patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Pharmacokinetics of an IgM human monoclonal antibody against Pseudomonas aeruginosa in nonseptic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Treatment of experimental Pseudomonas aeruginosa pneumonia with a human IgM monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

A human monoclonal antibody that protects mice against Pseudomonas-induced pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Transgenic milk as a method for the production of recombinant antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

New immunotype schema for Pseudomonas aeruginosa based on protective antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

7 January 2021

Occurrence of a common lipopolysaccharide antigen in standard and clinical strains of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

7 January 2021

Immunochemistry of Pseudomonas aeruginosa Lipopolysaccharides and High-Molecular-Weight Polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

7 January 2021

Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

7 January 2021

Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

7 January 2021

Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

7 January 2021

Three new major somatic antigens of Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

7 January 2021

Smooth lipopolysaccharide is the major protective antigen for mice in the surface extract from IATS serotype 6 contributing to the polyvalent Pseudomonas aeruginosa vaccine PEV.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

7 January 2021

Human monoclonal antibodies that protect mice against challenge with Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

7 January 2021

In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2803%2900312-4

7 January 2021

10.1016/S0008-6215(03)00312-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14670716%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference